DaxibotulinumtoxinA Injection for Treatment of Adductor Spasmodic Dysphonia
NCT05158166
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
22
Enrollment
OTHER
Sponsor class
Conditions
Adductor Spasmodic Dysphonia
Voice Disorders
Spasmodic Dysphonia
Interventions
DRUG:
DaxibotulinumtoxinA
Sponsor
University of California, San Francisco